Nov. 10, 2014 — For the treatment of peripheral artery disease in leg arteries above the knee, the IN.PACT Admiral drug ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
November 5, 2014 — Future prevention and treatment strategies for vascular diseases may lie in the evaluation of early ...
November 05, 2014
Nov. 5, 2014 — Enrollment is open for the Dual Epicardial and Endocardial Procedure (DEEP) clinical trial following U.S ...
November 05, 2014November 4, 2014 — Shockwave Medical announced that the company will present clinical results from DISRUPT PAD, a single ...
November 04, 2014
October 30, 2014 — Cardiovascular Systems Inc. announced that the first seven patients in Japan have been enrolled in ...
October 30, 2014October 29, 2014 — Restenosis, the recurrence of narrowing of the arteries after stenting, is a common risk of this ...
October 29, 2014October 23, 2014 — The use of stents has improved management and outcomes of coronary artery disease, and clinical ...
October 23, 2014October 21, 2014 — CardioDx Inc., a molecular diagnostics company specializing in cardiovascular genomics, today ...
October 21, 2014
October 20, 2014 — Boston Scientific Corp. has initiated the PLATINUM Diversity trial to evaluate the clinical ...
October 20, 2014October 16, 2014 — Sunshine Heart Inc. today announced the results of its feasibility study entitled “Ambulatory Extra ...
October 16, 2014October 16, 2014 - Neovasc Inc. has received conditional Investigational Device Exemption (IDE) approval from the U.S ...
October 16, 2014
October 16, 2014 — Using stents to keep neck arteries open is just as effective as invasive neck surgery for long-term ...
October 16, 2014
October 15, 2014 — Imricor Medical Systems, Inc. announced the first three cardiac ablation procedures were completed in ...
October 15, 2014October 15, 2014 — AtriCure, Inc. today announced enrollment in the ABLATE Post Approval Study (PAS) is complete.
As of ...
October 15, 2014October 15, 2014 — Novartis Pharmaceuticals Canada Inc. revealed, in the largest heart failure study to date, that its ...
October 15, 2014